Log on / register
Feedback | Support | My details
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer.
Morse MA, Garst J, Osada T, Khan S, Hobeika A, Clay TM, Valente N, Shreeniwas R, Sutton MA, Delcayre A, Hsu DH, Le Pecq JB, Lyerly HK
J Transl Med 2005 Feb 21, 3:9
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunity.
Hao S, Bai O, Li F, Yuan J, Laferte S, Xiang J
Immunology 2007 Jan, 120:90-102
[PubMed Central] [PubMed] [Related articles]

2.
Different types of in vitro generated human monocyte-derived dendritic cells release exosomes with distinct phenotypes.
Johansson SM, Admyre C, Scheynius A, Gabrielsson S
Immunology 2008 Apr, 123:491-9
[PubMed Central] [PubMed] [Related articles]

3.
Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha.
Viaud S, Terme M, Flament C, Taieb J, André F, Novault S, Escudier B, Robert C, Caillat-Zucman S, Tursz T, Zitvogel L, Chaput N
PLoS One 2009, 4:e4942
[PubMed Central] [PubMed] [Related articles]

4.
Exosome nanovesicles displaying G protein-coupled receptors for drug discovery.
Estelles A, Sperinde J, Roulon T, Aguilar B, Bonner C, LePecq JB, Delcayre A
Int J Nanomedicine 2007, 2:751-60
[PubMed Central] [PubMed] [Related articles]

5.
Exosomes in tumour immunity.
Clayton A, Mason MD
Curr Oncol 2009 May, 16:46-9
[PubMed Central] [PubMed] [Related articles]


This article is also cited by 1 article in BioMed Central

printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.